EUVIMEDОткрийте EUVIMED
Crossref

Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota

Peng Jiang, Yun Zhang, Xiaojie Li, Junyang Chen iD

Phytotherapy Research · 2023-08 · 37 (8) · 3453-3466

DOI: 10.1002/ptr.7819 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-04-26. Written by Peng Jiang and 3 co-authors. Institution: Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, China. Major MEDLINE topics: Gastrointestinal Microbiome, Colitis. Cited 33 times so far (Crossref); 43 references.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Geniposidic acid (GPA) is a bioactive compound isolated from Gardenia jasminoides Ellis ( Rubiaceae ) that has long been used to treat arthritis, jaundice, and hypertension. However, the therapeutic effects of GPA against colitis remain underexplored. This study aimed to investigate the effect of GPA on the remission of colitis and the underlying mechanisms. A DSS‐induced colitis mouse model was used to evaluate the influence of GPA on the modulation of gut microbiota and intestinal epithelial barrier function. Our results indicated that GPA improved DSS‐induced mouse colitis, including loss of body weight, disease activity index (DAI), colon length, and colonic pathological damage. DSS‐induced destruction of the intestinal barrier was also significantly repaired by GPA treatment. In addition, the relative levels of pro‐inflammatory cytokines, such as IL‐1β and TNF‐α, were markedly alleviated by GPA. Furthermore, western blot analysis revealed that GPA downregulated the protein expression of the nuclear transcription factor NF‐κB. Finally, we first demonstrated that GPA could alleviate gut microbiota dysbiosis in mice with colitis by bacterial 16S rRNA sequencing. In conclusion, our study demonstrates the therapeutic and protective effects of GPA on IBD and provides novel insights into the prevention of colitis by targeting gut microbiota metabolism using natural products.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeColitisAnimalsMiceRNA, Ribosomal, 16SInflammationColonDisease Models, AnimalDextran SulfateMice, Inbred C57BLIridoid Glucosides

Author keywords

NF-κBgeniposidic acidgut microbiotainflammatory bowel diseaseintestinal barrier

Substances

RNA, Ribosomal, 16SDextran Sulfategeniposidic acidIridoid Glucosides

Authors and institutions

  • Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • State Key Laboratory for Zoonotic Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun, China.
  • Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Department of Ophthalmology, Changchun People's Hospital, Changchun, China.

ORCID profiles: Junyang Chen

Cite

APA

Jiang, P., Zhang, Y., Li, X., & Chen, J. (2023). Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota. Phytotherapy Research, 37(8), 3453-3466. https://doi.org/10.1002/ptr.7819

Vancouver

Jiang P, Zhang Y, Li X, Chen J. Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota. Phytotherapy Research. 2023;37(8):3453-3466. doi:10.1002/ptr.7819

BibTeX
@article{Jiang2023,
  author = {Jiang, Peng and Zhang, Yun and Li, Xiaojie and Chen, Junyang},
  title = {Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {8},
  pages = {3453--3466},
  doi = {10.1002/ptr.7819}
}
Start for free →